Vitamins C, E May Help Prevent Pre-Eclampsia - Lancet Study
This article was originally published in The Tan Sheet
Executive Summary
Supplementation with vitamins C and E in patients at high risk for developing pre-eclampsia is associated with a significant effect on biochemical markers for the disease, researchers report in the Sept. 4 issue of The Lancet.
You may also be interested in...
Low-dose aspirin does not prevent preeclampsia in high-risk women, study finds.
LOW-DOSE ASPIRIN DOES NOT PREVENT PREECLAMPSIA IN HIGH-RISK WOMEN in a 2,503-subject study, Steve Caritis, MD, University of Pittsburgh, et al., report in the March 12 New England Journal of Medicine. The incidence of preeclampsia was 18% among the 1,254 high-risk women in the 60 mg low-dose aspirin group and 20% in the 1,249 high-risk women placebo group, leading the researchers to conclude low-dose aspirin does not provide a significant reduction in preeclampsia. Aspirin also did not improve perinatal outcomes in women at high risk for preeclampsia, the researchers say.
Calcium supplementation does not prevent preeclampsia, hypertension -- NICHD trial.
CALCIUM SUPPLEMENTATION DOES NOT PREVENT PREECLAMPSIA based on the results of a study in over 4,500 first-time pregnant women, Richard Levine, MD, National Institute of Child Health & Human Development et al., conclude in a study published in the July 10 issue of the New England Journal of Medicine. Taking calcium supplements during pregnancy also did not prevent pregnancy-associated hypertension or adverse perinatal outcomes in healthy women, the researchers found. The five-center study was funded by NICHD and the National Heart, Lung & Blood Institute.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC